Should a Terminal Patient Receive Cataract Surgery? Should a Terminal Patient Receive Cataract Surgery?
Should a terminally ill cancer patient who asks for cataract surgery to improve his quality of life be granted his wish?Medscape Business of Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 18, 2018 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news
FLACS vs Phaco for Cataract Extraction and IOL Implantation FLACS vs Phaco for Cataract Extraction and IOL Implantation
What benefits might femtosecond laser-assisted cataract surgery offer over conventional phacoemulsification?Current Opinion in Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 16, 2018 Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news
Combining Cataract Surgery, Baerveldt-tube Implant Sometimes Useful for Glaucoma Combining Cataract Surgery, Baerveldt-tube Implant Sometimes Useful for Glaucoma
Cataract surgery and implantation of a Baerveldt tube (BT) for glaucoma should be done separately in most cases, but may be combined in some, research from Switzerland suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 11, 2018 Category: Surgery Tags: Ophthalmology News Source Type: news
Cataract surgery may help women live longer, study suggests
By correcting vision trouble, the surgery may also help women in other ways (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - January 8, 2018 Category: Consumer Health News Source Type: news
Cataract surgery in older women may reduce risk of death, study shows
New study reveals a longer life might be an unexpected benefit of cataract surgery, the most frequently performed operation in the U.S. A large study of women links the eye procedure to a 60 percent lower risk of dying from all causes. Dr. Christopher Starr, an ophthalmologist at Weill Cornell Medical Center, joins "CBS This Morning" to discuss the findings. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - January 8, 2018 Category: Consumer Health News Source Type: news
Liberia:Prevail, Partners Perform 40 Successful Cataract Surgeries
[Observer] The Partnership for Research on Ebola Virus in Liberia (PREVAIL) recently conducted a clinical research study where Ebola survivors and their close contacts benefited from cataract removal surgeries. The study, called PREVAIL 7, sought to address the issues of safety for participants to undergo cataract surgery and to define the post-surgical care needed to achieve the best visual outcomes. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 8, 2018 Category: African Health Source Type: news
Liberia:Prevail Conducts Cataract Removal Surgeries
[New Dawn] The Partnership for Research on Ebola Virus in Liberia (PREVAIL) recently conducted a clinical research study where Ebola survivors and their close contacts benefitted from eye cataract removal surgeries. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 4, 2018 Category: African Health Source Type: news
Liberia:Prevail, Partners Perform 40 Successful Cataract Eye Surgeries
[FrontPageAfrica] Monrovia -The Partnership for Research on Ebola Virus in Liberia (PREVAIL) recently conducted a clinical research study where Ebola survivors and their close contacts benefitted from eye cataract removal surgeries. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 4, 2018 Category: African Health Source Type: news
Perrigo Announces Tentative FDA Approval For The Generic Version Of Prolensa(R) Ophthalmic Solution 0.07%
DUBLIN, Jan. 3, 2018 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE; TASE: PRGO) today announced it has received tentative approval from the U.S. Food and Drug Administration for the generic version of Prolensa® (bromfenac opht... Biopharmaceuticals, Generics, Ophthalmology, FDA Perrigo, bromfenac, Prolensa, cataract surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 3, 2018 Category: Pharmaceuticals Source Type: news
Glaukos files PMA bid for iStent Inject glaucoma treatment
Glaukos (NYSE:GKOS) said today that it filed for pre-market approval from the FDA of its iStent Inject trabecular micro-bypass stent for treating glaucoma.
San Clemente, Calif.-based Glaukos said the device is designed to treat mild-to-moderate open-angle glaucoma in patients undergoing cataract surgery. It used a pair of heparin-coated titanium stents in a pre-loaded auto-injection system that allows them to be injected into multiple trabecular meshwork locations via a single corneal entry point.
“This PMA submission marks a significant milestone for Glaukos as we continue to deliver our deep pipeline of novel gla...
Source: Mass Device - December 27, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Compliance Glaukos Source Type: news
Bringing Robotics into the Cath Lab to Protect Physicians
Percutaneous Coronary Intervention (PCI, or angioplasty with stent) is a common procedure used to treat patients with obstructive coronary artery disease, with an estimated 600,000 procedures performed annually in the United States. PCI has a low risk of complications for patients, but that's not the case for clinicians.
Patients receive a dose of radiation during a PCI procedure, which takes anywhere from 30 minutes to a few hours. Interventional cardiologists and cardiac catheterization laboratory personnel are exposed to ionizing radiation all day, every day. Protective measures, such as radiation safety caps, goggles...
Source: MDDI - December 15, 2017 Category: Medical Devices Authors: Heather R. Johnson Tags: Medical Device Business Source Type: news
'Green' cataract surgery model drastically reduces environmental footprint
(NYU Langone Health / NYU School of Medicine) Faculty at NYU School of Medicine report that a healthcare center in India's model for cataract surgery emits 96 percent less carbon than in the United Kingdom -- and a likely even greater savings in the United States -- while yielding comparable or better health outcomes for one of the world's most common surgical procedures. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 6, 2017 Category: International Medicine & Public Health Source Type: news
Eye health care placing avoidable pressure on GPs in London
Yet none of its five STPs explicitly mention eye health in their plans, and CCG spend lower than average Related items fromOnMedica Eye problems Eye problems: the eyelids Two thirds of eye units restricting access to cataract surgery STPs can help CCGs deliver eye care at scale (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 5, 2017 Category: UK Health Source Type: news
Personal Health: Cataract Surgery May Prolong Your Life
People who can see better are more likely to get exercise, take their medication and avoid falls, experts say. (Source: NYT Health)
Source: NYT Health - December 4, 2017 Category: Consumer Health News Authors: JANE E. BRODY Tags: Cataracts Eyes and Eyesight Surgery and Surgeons Women and Girls Elderly Source Type: news
FDA Approves UV-Light-Adjustable Intraocular Lens for Cataract Surgery
The FDA has approved an intraocular lens that can be adjusted with ultraviolet light therapy after cataract surgery to optimize a patient ' s vision without glasses... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 27, 2017 Category: Primary Care Source Type: news
